Vitamin B12 Supplementation Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00826657 |
Recruitment Status :
Completed
First Posted : January 22, 2009
Last Update Posted : May 21, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Vitamin B12 Deficiency | Dietary Supplement: Vitamin B12 Dietary Supplement: placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 180 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Triple (Participant, Care Provider, Outcomes Assessor) |
Primary Purpose: | Health Services Research |
Official Title: | Assessment of Functional Vitamin B12 Deficiency in Mexican Women |
Study Start Date : | October 2004 |
Actual Primary Completion Date : | August 2005 |
Actual Study Completion Date : | November 2006 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: placebo
Receive placebo (sugar pill) during the intervention. Received a 1000 mg vitamin B12 injection at the end of the study.
|
Dietary Supplement: placebo
placebo given as a daily supplement 1000 mg injection of vitamin B12 given at the end of the study
Other Name: sugar pill |
Active Comparator: Vitamin B12
Received 500 micrograms vitamin B12 per day during the study Received a 1000 mg vitamin B12 injection at the start of the study
|
Dietary Supplement: Vitamin B12
500 microgram daily supplement of vitamin B12 1000 mg injection vitamin B12 given at the start of the study |
- response to B12 supplementation in serum B12, Methylmalonic acid, homocystein, and holotranscobalamin concentrations [ Time Frame: 0 and 3 mos ]
- DNA methylation change, and hematological response to B12 supplementation [ Time Frame: 0 and 3 mos ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years to 59 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Women age 20-59, apparently healthy, no severe B12 deficiency
Exclusion Criteria:
- pregnancy, lactation, anemia and disease states

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00826657
Mexico | |
Universidad Autonoma de Queretaro | |
Queretaro, Mexico |
Responsible Party: | USDA, Western Human Nutrition Research Center |
ClinicalTrials.gov Identifier: | NCT00826657 |
Other Study ID Numbers: |
200412519-3 |
First Posted: | January 22, 2009 Key Record Dates |
Last Update Posted: | May 21, 2015 |
Last Verified: | May 2015 |
B12 deficiency methylmalonic acid homocystein vitamin B12 supplementation intervention |
Vitamin B 12 Deficiency Vitamin B Deficiency Avitaminosis Deficiency Diseases Malnutrition Nutrition Disorders Vitamin B 12 |
Hydroxocobalamin Vitamins Micronutrients Physiological Effects of Drugs Vitamin B Complex Hematinics |